Skip to main content
Caplight Logo









StratifAI GmbH

StratifAI GmbH

Private
BerlinHealthcare & Life Scienceshttps://www.stratifai.com/

Last Round

Early Funding

Sep 30, 2025

Total Funding Raised

$16.35M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

StratifAI GmbH is a precision oncology company that develops multimodal AI models to improve cancer diagnosis and treatment through its proprietary biomarker discovery platform, Polaris™.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Medical AI, Medical Imaging, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

precision oncologymultimodal AIAI biomarkerbiomarker discoveryclinical decision supportcomputational pathologyhistology image analysisAI diagnosticsprognostic testingdigital pathologyoncology AIRNASeq analysiscancer diagnosticsfoundation modelfrontier AI lab

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

StratifAI GmbH Comparables

Compare StratifAI GmbH with similar companies based on industry and business-model similarity.

StratifAI GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Imagene AI
82%
Aignostics
79%
BioAI Health
77%

StratifAI GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingSep 30, 2025
Pre SeedSep 2, 2024

Key People

Founding team and executive leadership

Firas Khader

CTO & Co-founder

Founding Team

Omar El Nahhas

CEO & Co-founder

Founding Team

StratifAI GmbH Investors

Notable investors and investment history

StratifAI GmbH investors
InvestorRounds
Neulogy VenturesPre Seed
Arve CapitalPre Seed, Early Funding
AlvenEarly Funding
Heliad AGEarly Funding
Picus CapitalEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 5, 2026

    Monthly visitors increased 82% MoM.

  • Nov 13, 2025

    Grew 27% QoQ, from 15 to 19 employees.

StratifAI GmbH Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

StratifAI GmbH Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about StratifAI GmbH's valuation, stock price, and market status.

Firmographic Details

HeadquartersBerlin
Employee Range14
Year Founded2023
Last FundingSep 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?